Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 132
Filtrar
1.
Int J Mol Sci ; 25(11)2024 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-38892261

RESUMO

Flatworms are known for their remarkable regenerative ability, one which depends on totipotent cells known as germinative cells in cestodes. Depletion of germinative cells with hydroxyurea (HU) affects the regeneration of the parasite. Here, we studied the reduction and recovery of germinative cells in T. crassiceps cysticerci after HU treatment (25 mM and 40 mM of HU for 6 days) through in vitro assays. Viability and morphological changes were evaluated. The recovery of cysticerci's mobility and morphology was evaluated at 3 and 6 days, after 6 days of treatment. The number of proliferative cells was evaluated using EdU. Our results show morphological changes in the size, shape, and number of evaginated cysticerci at the 40 mM dose. The mobility of cysticerci was lower after 6 days of HU treatment at both concentrations. On days 3 and 6 of recovery after 25 mM of HU treatment, a partial recovery of the proliferative cells was observed. Proteomic and Gene Ontology analyses identified modifications in protein groups related to DNA binding, DNA damage, glycolytic enzymes, cytoskeleton, skeletal muscle, and RNA binding.


Assuntos
Proliferação de Células , Hidroxiureia , Taenia , Hidroxiureia/farmacologia , Animais , Proliferação de Células/efeitos dos fármacos , Taenia/efeitos dos fármacos , Taenia/genética , Taenia/crescimento & desenvolvimento , Taenia/metabolismo , Proteômica/métodos , Proteínas de Helminto/metabolismo , Proteínas de Helminto/genética , Proteoma/metabolismo , Cysticercus/efeitos dos fármacos , Cysticercus/metabolismo
2.
Biomed Pharmacother ; 175: 116628, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38663106

RESUMO

Colorectal cancer (CRC) is one of the most prevalent fatal neoplasias worldwide. Despite efforts to improve the early diagnosis of CRC, the mortality rate of patients is still nearly 50%. The primary treatment strategy for CRC is surgery, which may be accompanied by chemotherapy and radiotherapy. The conventional and first-line chemotherapeutic agent utilized is 5-fluorouracil (5FU). However, it has low efficiency. Combination treatment with leucovorin and oxaliplatin or irinotecan improves the effectiveness of 5FU therapy. Unfortunately, most patients develop drug resistance, leading to disease progression. Here, we evaluated the effect of a potential alternative adjuvant treatment for 5FU, helminth-derived Taenia crassiceps (TcES) molecules, on treating advanced colitis-associated colon cancer. The use of TcES enhanced the effects of 5FU on established colonic tumors by downregulating the expression of the immunoregulatory cytokines, Il-10 and Tgf-ß, and proinflammatory cytokines, Tnf-α and Il-17a, and reducing the levels of molecular markers associated with malignancy, cyclin D1, and Ki67, both involved in apoptosis inhibition and the signaling pathway of ß-catenin. TcES+5FU therapy promoted NK cell recruitment and the release of Granzyme B1 at the tumor site, consequently inducing tumor cell death. Additionally, it restored P53 activity which relates to decreased Mdm2 expression. In vitro assays with human colon cancer cell lines showed that therapy with TcES+5FU significantly reduced cell proliferation and migration by modulating the P53 and P21 signaling pathways. Our findings demonstrate, for the first time in vivo, that helminth-derived excreted/secreted products may potentiate the effect of 5FU on established colon tumors.


Assuntos
Fluoruracila , Animais , Fluoruracila/farmacologia , Fluoruracila/uso terapêutico , Taenia/efeitos dos fármacos , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/patologia , Apoptose/efeitos dos fármacos , Citocinas/metabolismo , Camundongos , Humanos , Linhagem Celular Tumoral , Carcinogênese/efeitos dos fármacos , Granzimas/metabolismo , Proliferação de Células/efeitos dos fármacos , Camundongos Endogâmicos BALB C
3.
Acta Trop ; 221: 106027, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34216560

RESUMO

Cysticercosis is the presence of Taenia solium larval stage in tissues such as central nervous system, skin, muscles and eye globe. The current treatment is based on albendazole and praziquantel which already present resistance reports. Therefore, the search for alternative treatments is paramount. The aim of this study was to determine the effect of flubendazole and nitazoxanide on cytoskeleton proteins from Taenia crassiceps cysticerci, an experimental model for cysticercosis. Cysticerci were cultured in RPMI supplemented medium containing nitazoxanide and/or flubendazole. 24 h after the exposure the cysticerci were processed for scanning and transmission electron microscopy and for protein analysis of the cytoskeleton. The proteins were detected through 1D electrophoresis and identified through Western Blot. Nitazoxanide exposure increased tubulin and actin quantifications in T. crassiceps cysticerci. While flubendazole alone and the drugs combinations induced an increase in α-tubulin and actin and decreased ß-tubulin quantifications in the parasite. Morphological changes such as swelling and rupture of vesicle, stiff membrane, decrease in movements were observed when the cysticerci were incubated with the different compounds. In conclusion the drugs induced significative impact in the parasite`s cytoskeleton and may be considered as alternative treatments for cysticercosis.


Assuntos
Citoesqueleto/efeitos dos fármacos , Mebendazol/análogos & derivados , Nitrocompostos/farmacologia , Taenia , Tiazóis/farmacologia , Animais , Cisticercose , Cysticercus/efeitos dos fármacos , Feminino , Mebendazol/farmacologia , Camundongos , Camundongos Endogâmicos BALB C , Taenia/efeitos dos fármacos
4.
Parasitology ; 147(7): 822-827, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32234089

RESUMO

Neurocysticercosis (NCC) is the most common helminthic brain infection related to epilepsy. Only albendazole (ABZ) and praziquantel are used in its treatment. The development of new therapeutics has been encouraged. Taenia crassiceps cysticerci intracranial infection is the experimental model used in NCC studies. This study evaluated the histopathology of the brains of BALB/c mice experimentally infected with T. crassiceps cysticerci after the treatment with the ABZ/nitazoxanide (NTZ) combination. Thirty days after the inoculation the mice received an oral single dose of the ABZ/NTZ combination (40 mg kg-1 each). The control groups were treated with: NaCl 0.9%; ABZ or NTZ. The histopathologic evaluation of the brains was performed 24 h after treatment. The ABZ treatment induced discrete mononuclear inflammatory infiltration, meningitis, gliosis, hyperaemia and hippocampus compression; moderate ependimitis and oedema. The NTZ treatment induced accentuated inflammatory infiltration, foamy macrophages, ependimitis, choroiditis, gliosis and hyperaemia and moderate oedema. The ABZ/NTZ combination treatment induced a significant decrease in the polymorphonuclear inflammatory infiltration, ependimitis, choroiditis, gliosis, hyperaemia and ventriculomegaly in comparison with the other groups. The cysticerci showed destruction of the tegument not observed in other groups. The ABZ/NTZ combination is efficient as the parasite showed signs of destruction and lower damage to the host's tissue.


Assuntos
Albendazol/farmacologia , Anticestoides/farmacologia , Neurocisticercose/prevenção & controle , Taenia/efeitos dos fármacos , Tiazóis/farmacologia , Animais , Modelos Animais de Doenças , Combinação de Medicamentos , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Neurocisticercose/patologia , Nitrocompostos
5.
Acta Trop ; 206: 105448, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32194066

RESUMO

Taenia crassiceps is an experimental model used for cysticercosis studies and has suffered metabolic analyzes regarding the effect of anthelminthic drugs. The metabolic analyses are useful tools to determine the drugs mode of action and the parasite`s survival mechanisms. The energetic pathways are good candidates for this kind of approach as they are essential for the parasite`s survival and adaptation to the environment. In this review we discuss the anthelminthic drugs mode of action and its metabolic impact on Taenia crassiceps cysticerci.


Assuntos
Anti-Helmínticos/farmacologia , Cisticercose/tratamento farmacológico , Taenia/efeitos dos fármacos , Animais , Humanos , Larva/efeitos dos fármacos , Larva/metabolismo , Taenia/metabolismo
6.
Acta Trop ; 202: 105254, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31689380

RESUMO

The benzimidazole derivative, 6-chloro-5-(2,3-dichlorophenoxy)-2-(trifluoromethyl)-1H-benzimidazole (RCB15), has a similar mode of action and efficacy as albendazole, a commonly used anthelminthic drugs. The aim of this study was to evaluate its influence on the tricarboxylic acid cycle in Taenia crassiceps cysticerci. The parasites were cultured in supplemented RPMI medium containing albendazole sulfoxide (ABZSO) or RCB15, for 24 h. Then, frozen in liquid nitrogen for organic metabolites extraction. Samples were analyzed by high performance liquid chromatography and organic acids of the tricarboxylic acid cycle were detected. It was possible to observe changes in the concentrations of all acids involved in this metabolic pathway, with the exception of α-ketoglutarate, which was not detected in the control group neither in most of the treated groups. It indicates that the parasite presented a partial inhibition of the tricarboxylic acid cycle. The significant increase in the concentration of citrate, oxaloacetate and succinate in the RCB15 treated groups may indicate an activation of the fumarate reductase pathway, leading to metabolic distress. Therefore RCB15 may be considered an alternative for the treatment of tissue parasitic diseases, since it induced changes in the main metabolic pathway of the parasite.


Assuntos
Anti-Helmínticos/farmacologia , Benzimidazóis/farmacologia , Ciclo do Ácido Cítrico/efeitos dos fármacos , Cysticercus/efeitos dos fármacos , Taenia/efeitos dos fármacos , Animais , Cysticercus/metabolismo , Redes e Vias Metabólicas/efeitos dos fármacos , Camundongos Endogâmicos BALB C , Taenia/metabolismo
7.
Acta Trop ; 202: 105238, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31669532

RESUMO

The current pharmacological treatment of neurocysticercosis is based on two drugs, praziquantel (PZQ) and albendazole; however, suboptimal efficacy has been documented. Previous studies, have documented the activity of mebendazole (MBZ) against Taenia sp, and its capability to cross the blood-brain barrier. Considering this information and in an effort to search other options for neurocysticercosis treatment, the present study was designed to assess the in vitro and in vivo activity of the PZQ-MBZ combination against Taenia crassiceps metacestodes. For the in vitro studies T. crassiceps cysticerci (ORF strain) were used and the analysis of the combinations was performed using the Surface of Synergistic Interaction (SSI). For the in vivo evaluation the experimental infection model of T. crassiceps ORF in Balb-C mice was used. In vitro results showed that the combination of PZQ 121.6 nM-MBZ 5.1 nM exhibited the highest synergic cysticidal effect. In vivo, the PZQ-MBZ combination (25 mg/kg - 50 mg/kg, respectively) was more effective than each drug alone. The findings indicate that PZQ in combination with MBZ could be a promising alternative for the treatment of neurocysticercosis. Complementary studies are required to confirm its clinical applicability.


Assuntos
Anti-Helmínticos/uso terapêutico , Cisticercose/tratamento farmacológico , Mebendazol/uso terapêutico , Neurocisticercose/tratamento farmacológico , Praziquantel/uso terapêutico , Albendazol/uso terapêutico , Animais , Barreira Hematoencefálica , Combinação de Medicamentos , Camundongos , Camundongos Endogâmicos BALB C , Neurocisticercose/parasitologia , Taenia/efeitos dos fármacos
8.
Exp Parasitol ; 208: 107801, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31730781

RESUMO

Taenia solium is a parasite whose larvae (cysticerci) can locate in the central nervous system of humans and cause neurocysticercosis (NC). The introduction of cysticidal drugs such as albendazole (ABZ) for the treatment of NC has significantly improved its prognosis. However, treatment is not always effective, and the high levels of corticosteroids used to prevent inflammatory complications in this disease could be, partly, the cause of this observation. In this context, this study investigated, using the experimental mouse model of intraperitoneal infection with Taenia crassiceps, the influence of corticosteroid administration on the therapeutic efficacy of ABZ. We evaluated and compared the effects of ABZ, dexamethasone (DXM) and their combination (ABZ + DXM) on cyst viability, both in vitro and in vivo. Serum levels of IL-4, IFN-gamma, IL-6 and IL-10 were evaluated in the in vivo study. Results showed that the treatment with ABZ, in vitro and in vivo, was associated with a high number of parasites deaths. Concomitant treatment with DXM did not alter ABZ in vitro cysticidal activity but reduced its effectiveness significantly in the in vivo experimental model. Cytokine serum levels did not change significantly in treated mice compared to the controls. The results of this study are relevant as they indicate a negative effect of corticosteroids on the efficacy of cysticidal therapy. In human neurocysticercosis, control of inflammation is of great importance to most patients in order to avoid complications. Corticosteroids are generally used for this purpose and the results of this study demonstrate the need to find other therapeutic strategies. Further studies are needed to better understand the mechanisms involved.


Assuntos
Albendazol/farmacologia , Anti-Helmínticos/farmacologia , Anti-Inflamatórios/farmacologia , Cisticercose/tratamento farmacológico , Dexametasona/farmacologia , Taenia/efeitos dos fármacos , Albendazol/uso terapêutico , Animais , Anti-Helmínticos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Dexametasona/uso terapêutico , Interações Medicamentosas , Ensaio de Imunoadsorção Enzimática , Feminino , Interferon gama/sangue , Interleucina-10/sangue , Interleucina-4/sangue , Interleucina-6/sangue , Camundongos , Camundongos Endogâmicos BALB C
9.
Exp Parasitol ; 208: 107792, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31707003

RESUMO

Nitazoxanide (NTZ) is a broad-spectrum drug used in intestinal infections, but still poorly explored in the treatment of parasitic tissular infections. This study aimed to evaluate the in vitro responses of the energetic metabolism of T. crassiceps cysticerci induced by NTZ. The organic acids of the tricarboxylic acid cycle, products derived from fatty acids oxidation and protein catabolism were analyzed. These acids were quantified after 24 h of in vitro exposure to different NTZ concentrations. A positive control group was performed with albendazole sulfoxide (ABZSO). The significant alterations in citrate, fumarate and malate concentrations showed the NTZ influence in the tricarboxylic acid (TCA) cycle. The non-detection of acetate confirmed that the main mode of action of NTZ is effective against T. crassiceps cysticerci. The statistical differences in fumarate, urea and beta-hydroxybutyrate concentrations showed the NTZ effect on protein catabolism and fatty acid oxidation. Therefore, the main energetic pathways such as the TCA cycle, protein catabolism and fatty acids oxidation were altered after in vitro NTZ exposure. In conclusion, NTZ induced a significant metabolic stress in the parasite indicating that it may be used as an alternative therapeutic choice for cysticercosis treatment. The use of metabolic approaches to establish comparisons between anti parasitic drugs mode of actions is proposed.


Assuntos
Antiparasitários/farmacologia , Taenia/efeitos dos fármacos , Tiazóis/farmacologia , Albendazol/análogos & derivados , Albendazol/farmacologia , Análise de Variância , Animais , Anti-Helmínticos/farmacologia , Citratos/metabolismo , Ciclo do Ácido Cítrico/efeitos dos fármacos , Meios de Cultura/química , Cysticercus/efeitos dos fármacos , Cysticercus/metabolismo , Metabolismo Energético/efeitos dos fármacos , Fumaratos/metabolismo , Ácidos Cetoglutáricos/metabolismo , Malatos/metabolismo , Neurocisticercose/tratamento farmacológico , Nitrocompostos , Ácido Oxaloacético/metabolismo , Ácido Succínico/metabolismo , Taenia/metabolismo
10.
Chem Pharm Bull (Tokyo) ; 67(12): 1293-1300, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31787656

RESUMO

Based on our previous research on cysticidal drugs, we report the synthesis and evaluation of three new benzimidazole derivatives. In these compounds, the amido group was used as a bioisosteric replacement of the ester group. The molecular docking on ß-tubulin revealed that the derivatives interacted through hydrogen bonding with N165, E198 and V236. All compounds showed in vitro activity against Taenia crassiceps cysts. Among them, benzimidazole 3 was found to be the most potent of the series (EC50 0.86 µM). This compound also exhibited the highest probability of binding and the lowest binding free energy score and was therefore selected for in vivo evaluation. Results indicated that the efficacy of compound 3 was comparable to that of the reference drug, albendazole (50.39 vs. 47.16% parasite reduction). Animals treated with compound 3 seemed to tolerate this benzimidazole well, with no changes in behavior, or food and water consumption. These findings are consistent with the in silico prediction results, which indicated low toxicity risks. The pharmacokinetic study showed that the half-life and mean residence time (6.06 and 11.9 h, respectively) were long after oral administration. Together, these results indicate that this new benzimidazole derivative represents a promising structure with cysticidal activity.


Assuntos
Amebicidas/farmacologia , Benzimidazóis/farmacologia , Cisticercose/tratamento farmacológico , Simulação de Acoplamento Molecular , Taenia/efeitos dos fármacos , Amebicidas/síntese química , Amebicidas/química , Animais , Benzimidazóis/síntese química , Benzimidazóis/química , Relação Dose-Resposta a Droga , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Estrutura Molecular , Relação Estrutura-Atividade
11.
PLoS One ; 14(7): e0220098, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31329647

RESUMO

Curcuma is a traditional ingredient of some Eastern cuisines, and the spice is heralded for its antitumoral and antiparasitic properties. In this report, we examine the effect of the curcuminoides which include curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC), as well as curcumin degradation products on thioredoxin glutathione reductase from Taenia crassiceps cysticerci Results revealed that both DMC and BDMC were inhibitors of TGR activity in the micromolar concentration range. By contrast, the inhibitory ability of curcumin was a time-dependent process. Kinetic and spectroscopical evidence suggests that an intermediary compound of curcumin oxidation, probably spiroepoxide, is responsible. Preincubation of curcumin in the presence of NADPH, but not glutathione disulfide (GSSG), resulted in the loss of its inhibitory ability, suggesting a reductive stabilizing effect. Similarly, preincubation of curcumin with sulfhydryl compounds fully protected the enzyme from inhibition. Degradation products were tested for their inhibitory potential, and 4-vinylguaiacol was the best inhibitor (IC50 = 12.9 µM), followed by feruloylmethane (IC50 = 122 µM), vanillin (IC50 = 127 µM), and ferulic aldehyde (IC50 = 180 µM). The acid derivatives ferulic acid (IC50 = 465 µM) and vanillic acid (IC50 = 657 µM) were poor inhibitors. On the other hand, results from docking analysis revealed a common binding site on the enzyme for all the compounds, albeit interacting with different amino acid residues. Dissociation constants obtained from the docking were in accord with the inhibitory efficiency of the curcumin degradation products.


Assuntos
Anti-Helmínticos/farmacologia , Curcumina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Proteínas de Helminto/antagonistas & inibidores , Complexos Multienzimáticos/antagonistas & inibidores , NADH NADPH Oxirredutases/antagonistas & inibidores , Taenia/enzimologia , Animais , Anti-Helmínticos/química , Sítios de Ligação , Curcumina/farmacologia , Inibidores Enzimáticos/química , Proteínas de Helminto/química , Proteínas de Helminto/metabolismo , Simulação de Acoplamento Molecular , Complexos Multienzimáticos/química , Complexos Multienzimáticos/metabolismo , NADH NADPH Oxirredutases/química , NADH NADPH Oxirredutases/metabolismo , Ligação Proteica , Taenia/efeitos dos fármacos
12.
Korean J Parasitol ; 57(3): 243-248, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31284346

RESUMO

The purpose of this study was 2-fold: 1) to investigate the prevalence of gastrointestinal parasite infection in cats reared in Daegu, Republic of Korea and 2) to assess the efficacy and safety of a topical emodepside/praziquantel formulation for cats with parasitic infections. The gastrointestinal parasite infections were examined microscopically using the flotation method. Of 407 cats, 162 (39.8%) were infected by at least one gastrointestinal parasite, including Toxocara cati (63.0%), Toxascaris leonina (31.5%), Taenia taeniaeformis (3.7%), and Cystoisospora felis (1.9%). None of the infected animals had multiple infections. When the data were analyzed according to sex, age, and type of cat, stray cats showed statistically higher prevalence than companion cats (P<0.05). On the 5th day after treatment, no parasitic eggs were detected using microscopic examination. In addition, no adverse effects, such as abnormal behaviors and clinical symptoms, were observed in the cats treated with the drug. These results quantify the prevalence of gastrointestinal parasites in cats in Daegu, Republic of Korea, and show that topical emodepside/praziquantel is a safe and effective choice for treating the parasitic infections in cats.


Assuntos
Anti-Helmínticos/administração & dosagem , Doenças do Gato/tratamento farmacológico , Depsipeptídeos/administração & dosagem , Trato Gastrointestinal/parasitologia , Enteropatias Parasitárias/veterinária , Praziquantel/administração & dosagem , Animais , Doenças do Gato/parasitologia , Gatos , Composição de Medicamentos , Quimioterapia Combinada , Feminino , Enteropatias Parasitárias/tratamento farmacológico , Enteropatias Parasitárias/parasitologia , Masculino , República da Coreia , Taenia/efeitos dos fármacos , Taenia/isolamento & purificação , Taenia/fisiologia , Toxascaris/efeitos dos fármacos , Toxascaris/isolamento & purificação , Toxascaris/fisiologia , Toxocara/efeitos dos fármacos , Toxocara/isolamento & purificação , Toxocara/fisiologia
13.
J Helminthol ; 93(5): 539-547, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30149822

RESUMO

Androgens have been shown to exert a cysticidal effect upon Taenia crassiceps, an experimental model of cysticercosis. To further inquire into this matter, the Taenia crassiceps model was used to evaluate the expression of several proteins after testosterone (T4) and dihydrotestosterone (DHT) in vitro treatment. Under 2-D proteomic maps, parasite extracts were resolved into approximately 130 proteins distributed in a molecular weight range of 10-250 kDa and isoelectrical point range of 3-10. The resultant proteomic pattern was analysed, and significant changes were observed in response to T4 and DHT. Based on our experience with electrophoretic patterns and proteomic maps of cytoskeletal proteins, alteration in the expression of isoforms of actin, tubulin and paramyosin and of other proteins was assessed. Considering that androgens may exert their biological activity in taeniids through the non-specific progesterone receptor membrane component (PGRMC), we harnessed bioinformatics to propose the identity of androgen-regulated proteins and establish their hypothetical physiological role in the parasites. These analyses yield a possible explanation of how androgens exert their cysticidal effects through changes in the expression of proteins involved in cytoskeletal rearrangement, dynamic vesicular traffic and transduction of intracellular signals.


Assuntos
Androgênios/farmacologia , Morte Celular , Proteoma , Taenia/efeitos dos fármacos , Taenia/fisiologia , Actinas/genética , Animais , Biologia Computacional , Cisticercose/patologia , Cysticercus/efeitos dos fármacos , Cysticercus/fisiologia , Citoesqueleto/efeitos dos fármacos , Citoesqueleto/genética , Di-Hidrotestosterona/farmacologia , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Receptores de Progesterona/genética , Testosterona/farmacologia , Tropomiosina/genética , Tubulina (Proteína)/genética
14.
Acta Trop ; 190: 361-364, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30553893

RESUMO

Neurocysticercosis is the most frequent helminthiasis of the central nervous system and is caused by the presence of Taenia solium cysticerci. Nitazoxanide (NTZ) is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antiprotozoal activity due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme which is essential to anaerobic energy metabolism. The aim of this work was to determine the effect of NTZ on the energetic metabolism of Taenia crassiceps cysticerci intracranially inoculated BALB /c mice. The infected animals were treated with a single oral dose of NTZ 30 days after the inoculation. Analysis of the organic acids was performed through high performance liquid chromatography. Glucose was detected only in the treated groups, alongside with a significant decrease in lactate, pyruvate and oxaloacetate concentrations which indicate an increase in gluconeogenesis. The non-detection of alpha-ketoglutarate indicated the use of the fumarate reductase pathway in all groups. It was possible to confirm the drugs mode of action due to the non-detection of acetate in the treated groups. There was an increase in the fatty acids oxidation. Therefore it was possible to observe that NTZ induces gluconeogenesis as well as the increase of alternative energetic pathways such as fatty acids oxidation in T. crassiceps cysticerci.


Assuntos
Anti-Helmínticos/farmacologia , Cysticercus/metabolismo , Gluconeogênese/efeitos dos fármacos , Neurocisticercose/metabolismo , Taenia/metabolismo , Tiazóis/farmacologia , Administração Oral , Animais , Anti-Helmínticos/uso terapêutico , Cromatografia Líquida de Alta Pressão , Cysticercus/efeitos dos fármacos , Metabolismo Energético/efeitos dos fármacos , Ácidos Graxos/metabolismo , Glucose/metabolismo , Ácido Láctico/metabolismo , Redes e Vias Metabólicas/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Neurocisticercose/tratamento farmacológico , Nitrocompostos , Ácido Oxaloacético/metabolismo , Oxirredução , Ácido Pirúvico/metabolismo , Taenia/efeitos dos fármacos , Tiazóis/uso terapêutico
15.
Parasitol Res ; 117(5): 1581-1590, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29574514

RESUMO

The efficacy of anthelmintic treatment at 1, 3, and 6 month intervals was evaluated in a prospective controlled field study with naturally exposed Lithuanian village dogs by monthly coproscopy during 1 year. A placebo-treated control group (C) (n = 202) and groups treated with two broad-spectrum anthelmintics, febantel/pyrantel-embonate/praziquantel (Drontal® Plus, Bayer) (D1, D3, D6; n = 113-117) and emodepside/praziquantel (Profender®, Bayer) (P1, P3, P6; n = 114-119), were included. At the beginning of the study, eggs of Toxocara canis (4.02%) and T. cati (0.44%) identified morphometrically and/or molecularly and eggs of taeniid- (0.78%) and Capillaria-like eggs (5.03%) were present in the feces without significant differences in prevalence between groups. Significant decreases in excretion of T. canis eggs was found 1 month after the treatment with Drontal® Plus in February (D1) and with Profender® in October (P1), November (P1), December (P3), February (P1), and March (P1, P3), as compared to controls in the same months. The incidence of egg excretion per dog at least once a year was significantly lower in group P1 for T. canis (4.24%; p < 0.01) and in groups D1, P1 for taeniid eggs (0%; p < 0.01 and p < 0.001), when compared to controls (16.96 and 6.70%, respectively). A critical analyses of factors possibly responsible for intestinal passage of canine helminth eggs revealed that chained dogs excreted T. canis eggs more frequently 1 month after treatment compared to dogs in pens, particularly from November to March (p = 0.01). The incidence of single detection of T. cati eggs was significantly increased in chained dogs (12.46%) as compared to fenced dogs (1.08%; p = 0.0001).


Assuntos
Anti-Helmínticos/uso terapêutico , Depsipeptídeos/uso terapêutico , Doenças do Cão/tratamento farmacológico , Doenças do Cão/parasitologia , Guanidinas/uso terapêutico , Contagem de Ovos de Parasitas/veterinária , Praziquantel/uso terapêutico , Pamoato de Pirantel/uso terapêutico , Teníase/tratamento farmacológico , Toxocaríase/tratamento farmacológico , Animais , Cães , Fezes/parasitologia , Feminino , Intestinos/parasitologia , Lituânia , Estudos Longitudinais , Estudos Prospectivos , Taenia/efeitos dos fármacos , Teníase/veterinária , Toxocara canis/efeitos dos fármacos , Resultado do Tratamento
16.
Parasitol Res ; 116(11): 3037-3041, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28914356

RESUMO

Taenia crassiceps cysticerci are used as experimental model to study the host-parasite relationship and treatment of cysticercosis. One of the described mode of actions of nitazoxanide (NTZ) is to block the pyruvate ferredoxine oxidoreductase (PFOR) enzyme which is an essential enzyme to the parasite metabolism. The aim of this study was to determine the in vivo influence of one dosage of NTZ on the energetic metabolism of T. crassiceps cysticerci. Thirty days after the intraperitoneal inoculation of T. crassiceps cysticerci, BALB/c mice were orally treated with 7.5 mg/kg of NTZ. The control group was treated with physiologic solution (NaCl 0.9%). After 24 h, the animals were euthanized and the cysticerci were removed, washed, and processed for biochemical analysis. The organic acids detection occurred through high-performance liquid chromatographic and spectrophotometric analysis. While there was no difference in the glucose dosages, it was possible to observe a significant increase in the lactate concentrations and a decrease in the pyruvate concentrations of the NTZ-treated groups when compared to the control group. Also, there was a decrease in the urea and alpha-ketoglutarate concentrations. This probably occurred due to the impairment of the parasite's PFOR and nitroreductases leading an impairment of the mitochondrial aerobic pathways. In conclusion, the in vivo NTZ treatment leads to an increase in the lactic fermentation and to a decrease in the protein catabolism in T. crassiceps cysticerci.


Assuntos
Anticestoides/uso terapêutico , Cisticercose/tratamento farmacológico , Taenia/efeitos dos fármacos , Tiazóis/uso terapêutico , Anaerobiose , Animais , Cromatografia Líquida de Alta Pressão , Cisticercose/parasitologia , Metabolismo Energético/efeitos dos fármacos , Feminino , Glucose/metabolismo , Interações Hospedeiro-Parasita , Ácidos Cetoglutáricos/metabolismo , Ácido Láctico/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Nitrocompostos , Taenia/metabolismo
17.
Acta Trop ; 170: 1-7, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28216368

RESUMO

Currently, neurocysticercosis treatment involves two drugs: albendazole and praziquantel; however, their efficacy is suboptimal and new cysticidal drugs are needed. The present paper reports the cysticidal activity of extracts of the bark from Prunus serotina against Taenia crassiceps cysts and the isolation and identification of the main components of the most active extract. Results showed that all extracts displayed in vitro cysticidal activity (EC50=17.9-88.5µg/mL), being the methanolic the most active and selective. Also, methanolic extract exhibited in vivo efficacy at 300mg/kg which was similar to that obtained with albendazole. Bio-guided fractionation of methanolic extract led the isolation of 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one (naringenin, NGN), 3,4,5-trimethoxybenzoic acid and 1,3,5-trimethoxybenzene. NGN exhibited in vitro activity, in a time-concentration-dependent manner (EC50=89.3µM]. Furthermore, NGN at a dose of 376.1µmol/kg displayed similar in vivo efficacy than those obtained with albendazole at 188.4µmol/kg. NGN also caused a high level of damage in all parasite tissue in a similar manner than that observed with the methanolic extract. This study represents the first report of the cysticidal properties of the bark of P. serotina. NGN was identified as the main active compound of this specie and other studies are required to explore the potential of this flavanone as cysticidal agent.


Assuntos
Anti-Helmínticos/farmacologia , Cisticercose/tratamento farmacológico , Flavanonas/farmacologia , Extratos Vegetais/farmacologia , Prunus avium , Taenia/efeitos dos fármacos , Albendazol/farmacologia , Animais , Feminino , Camundongos , Camundongos Endogâmicos BALB C
18.
Exp Parasitol ; 171: 17-22, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27751770

RESUMO

Nitazoxanide (NTZ) is a broad-spectrum anti-parasitic drug used against a wide variety of protozoans and helminthes. Albendazole, its active metabolite albendazole sulfoxide (ABZSO), is one of the drugs of choice to treat both intestinal and tissue helminth and protozoan infections. However little is known regarding their impact on the metabolism of parasites. The aim of this study was to compare the in vitro effect of NTZ and ABZSO in the glycolysis of Taenia crassiceps cysticerci. The cysticerci were treated with 1.2; 0.6; 0.3 or 0.15 µg/mL of NTZ or ABZSO. Chromatographic and spectrophotometric analyses were performed in the culture medium and in the cysticerci extract. Regarding the glucose concentrations was possible to observe two responses: impair of the uptake and gluconeogenesis. The pyruvate concentrations were increased in the ABZSO treated group. Lactate concentrations were increased in the culture medium of NTZ treated groups. Therefore it was possible to infer that the metabolic acidosis was greater in the group treated with NTZ than in the ABZSO treated group indicating that this is one of the modes of action used by this drug to induce the parasite death.


Assuntos
Albendazol/análogos & derivados , Antiparasitários/farmacologia , Taenia/efeitos dos fármacos , Tiazóis/farmacologia , Albendazol/farmacologia , Animais , Anticestoides/farmacologia , Feminino , Glucose/metabolismo , Glicólise/efeitos dos fármacos , Ácido Láctico/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Nitrocompostos , Ácido Pirúvico/metabolismo , Taenia/crescimento & desenvolvimento , Taenia/metabolismo
19.
Acta Trop ; 161: 100-5, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27269203

RESUMO

The aim of this work was to develop nanosuspensions of praziquantel (PZQ) and to evaluate their influence on the energetic metabolism of cysticerci inoculated in BALB/c mice. We analyzed metabolic alterations of glycolytic pathways and the tricarboxylic acid cycle in the parasite. The nanosuspensions were prepared by precipitation and polyvinyl alcohol (PVA), poloxamer 188 (P188) and poloxamer 407 (P407) were used as stabilizers. Nanosuspension prepared with PVA had a particle size of 100nm, while P188- and P407-based nanosuspensions had particle sizes of 74nm and 285nm, respectively. The zeta potential was -8.1, -8.6, and -13.2 for the formulations stabilized with PVA, P188 and P407, respectively. Treatments of T. crassiceps cysticerci-infected mice resulted in an increase in glycolysis organic acids, and enhanced the partial reversion of the tricarboxylic acid cycle, the urea cycle and the production of ketonic bodies in the parasites when compared to the groups treated with conventional PZQ. These data suggest that PZQ nanosuspensions greatly modified the energetic metabolism of cysticerci in vivo. Moreover, the remarkable metabolic alterations produced by the stabilizers indicate that further studies on nanoformulations are required to find potentially suitable nanomedicines.


Assuntos
Cisticercose/tratamento farmacológico , Cisticercose/fisiopatologia , Cysticercus/efeitos dos fármacos , Cysticercus/metabolismo , Praziquantel/uso terapêutico , Taenia/efeitos dos fármacos , Taenia/metabolismo , Animais , Camundongos , Camundongos Endogâmicos BALB C , Nanopartículas
20.
Parasitology ; 143(4): 488-93, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26707797

RESUMO

Biochemical studies of benzimidazole derivatives are important to determine their mode of action and activity against parasites. The lack of antihelminthic alternatives to treat parasitic infections and albendazole resistance cases make the search for new antiparasitary drugs of utmost importance. The 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H-benzimidazole (RCB20) is a benzimidazole derivative with promising effect. This study evaluated the effect of different concentrations of RCB20 in the alternative energetic pathway of in vitro Taenia crassiceps cysticerci. The parasites were in vitro exposed to 6.5 and 13 µM of RCB20 and albendazole sulfoxide (ABZSO). The quantification of acetate, acetoacetate, ß-hydroxybutyrate, fumarate and propionate was performed by high-performance liquid chromatography. The quantification of urea, creatinine and total proteins was performed by spectrophotometry. The increase in ß-hydroxybutyrate reflects the enhancement of the fatty acid oxidation in the treated groups. Volatile fatty acids secretion, acetate and propionate, was increased in the treated groups. The secretion mechanisms of the treated parasites were impaired due to organic acids increased concentrations in the cysticerci. It is possible to conclude that the metabolic effect on alternative energetic pathways is slightly increased in the parasites treated with RCB20 than the ones treated with ABZSO.


Assuntos
Albendazol/análogos & derivados , Anticestoides/farmacologia , Benzimidazóis/farmacologia , Cysticercus/efeitos dos fármacos , Metabolismo Energético/efeitos dos fármacos , Ácido 3-Hidroxibutírico/metabolismo , Acetoacetatos/metabolismo , Albendazol/farmacologia , Animais , Creatinina/análise , Meios de Cultura/química , Cysticercus/metabolismo , Fumaratos/análise , Camundongos , Propionatos/metabolismo , Proteínas/análise , Taenia/efeitos dos fármacos , Taenia/metabolismo , Ureia/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...